Pacira BioSciences Stock Forecast
Recent Pacira BioSciences Stock Price |
|
Pacira BioSciences Stock Forecast Price |
$25.50 |
+81.57% |
$46.30 |
As of 2024-04-26
Recent Pacira BioSciences Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
7 |
7 |
7 |
8 |
Buy ratings: |
3 |
3 |
3 |
3 |
Hold ratings: |
0 |
0 |
0 |
0 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
0 |
0 |
Average rating: |
1.3 |
1.3 |
1.3 |
1.27 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Pacira BioSciences stock forecast (traded under symbol PCRX), for forward-twelve-months price target as shown at the top of this page, gives you the average Pacira BioSciences stock forecast for forward target price for symbol PCRX, across the 10 analysts covering Pacira BioSciences (PCRX), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Pacira BioSciences stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Pacira BioSciences stock forecast and half had a lower Pacira BioSciences stock forecast) was $45.0 as of 2024-04-26 (which is a different mathematical metric versus taking the average or mean), while the
highest Pacira BioSciences stock forecast in the analyst group was $57.0, and the lowest Pacira BioSciences stock forecast in the analyst group was
$36.0, with a standard deviation of $6.684. Get the latest Zacks research report on PCRX — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
Company Name: |
Pacira BioSciences Inc |
Website: |
www.pacira.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding PCRX: |
55 |
Total Market Value Held by ETFs: |
$290.52M |
Total Market Capitalization: |
$1.20B |
% of Market Cap. Held by ETFs: |
24.13% |
|
|
April 28, 2024 6:29 PM Eastern
Strong Buy (3.70 out of 4)
68th percentile
|
|